After nearly two decades of legal battles and negotiations, South Africa is moving to cut the cost of medicines with policies to increase imports and local production of generic drugs.
Articles on HIV/AIDS pandemic
Displaying 21 - 21 of 21 article
Top contributors
-
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
-
Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand
-
Associate Professor and Course Leader: Post Graduate Programmes in Clinical Pharmacy in the Department of Pharmacy, Sefako Makgatho Health Sciences University
-
Research Professor and DST/NRF SARChI Chair of Virus-Host Dynamics, National Institute for Communicable Diseases, CAPRISA Research Associate, University of the Witwatersrand
-
Head: Cell Biology, Centre for HIV and STIs, National Institute for Communicable Diseases
-
Research Associate/Post Doctoral Researcher and Deputy Laboratory Director at the Botswana Harvard AIDS Institute, Harvard University
-
Medical Scientist at the National Institute for Communicable Diseases; Research Associate at CAPRISA; Research Professor in the School of Pathology, University of the Witwatersrand
-
Senior Researcher, University of Cape Town
-
Professor of Geography, Penn State
-
Epidemiologist and Public Health Specialist, National Institute for Communicable Diseases
-
PhD candidate, Ghent University
-
Professor of Immunology, Infectious Diseases and Microbiology, University of Pittsburgh
-
Professor, School of Health Sciences, University of Northern British Columbia; University of Victoria
-
Assistant Professor of Health Behavior and Health Promotion, The Ohio State University
-
Lecturer in Media and International Development, University of East Anglia; Independent Social Research Foundation